Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Clinical Trial1
- Clinical Study1
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Encephale1
Search Results
Sort by
- Bookby Amy McGregor.Contents:
The autonomic nervous system
Behavioral neurology
Cerebrovascular disease
Congenital disorders including neurocutaneous disorders
Critical care and trauma
Dementia
Demyelinating diseases and neuroimmunology
Epilepsy
Metabolic disorders
Movement disorders
Neuroanatomy
Neurochemistry
Neurogenetics
Neuroinfectious disease
Neurologic complications of systemic diseases
Neuromuscular disease
Neuro-oncology
Neuro-ophthalmology
Neuro-otology
Neuropathology
Neuropharmacology
Neurophysiology
Neurotoxicology
Pain and headache
Pediatric neurology
Psychiatry
Sleep disorders
Substance abuse
Vitamin deficiency and excess.Digital Access Oxford [2016] - ArticleCocchi R, Mastruzzo A, Ciccone A, Osvaldi ML.Encephale. 1977;3(2):121-32.In a division of the neuropsychiatric hospital of Racconigi, with acute and chronic inpatients, the use of 1-glutamine and N-dipropylacetic acid as subsidiary psychodrugs, after one year follow-up, showed to have reduced the whole administration of neuroleptics, without diminishing the therapeutic efficacity. This administration, during the four sampler months (December, March, June and September), face with the sames of the preceding year, has been lesser than 29,04% (lesser than 38,21%, if we take into consideration the last two months). Such result has been confirmed by a corresponding diminution of orphenadrine, the drug used to counteract the neuroleptic syndrome, which during the last two months considered in this research, respectively subsided of 28,57% and 36,36%.